Withdrawal from Iran Nuclear Deal: A Legal Analysis
The US is no longer complying with the Iran nuclear deal and is poised to re-impose some previously lifted sanctions on Iran and its trading partners.
But the legal basis for that action is a bit murky and contested. A new analysis from the Congressional Research Service tries to make legal sense of what has happened.
“The legal framework for withdrawal from an international pact depends on, among other features, the type of pact at issue and whether withdrawal is analyzed under domestic law or international law,” the report says. See Withdrawal from the Iran Nuclear Deal: Legal Authorities and Implications, CRS Legal Sidebar, May 17, 2018.
Other new and updated reports from the Congressional Research Service include the following.
Iran’s Foreign and Defense Policies, updated May 23, 2018
Israel: Background and U.S. Relations In Brief, updated May 21, 2018
Bilateral and Regional Trade Agreements: Issues for Congress, May 17, 2018
Covert Action and Clandestine Activities of the Intelligence Community: Framework for Congressional Oversight In Brief, May 15, 2018
Military Construction: Process, Outcomes, and Frequently Asked Questions, updated May 16, 2018
The Federal Budget: Overview and Issues for FY2019 and Beyond, May 22, 2018
Violence Against Journalists in Mexico: In Brief, May 17, 2018
Venezuela’s 2018 Presidential Elections, CRS Insight, May 24, 2018
DACA Rescission: Legal Issues and Litigation Status, CRS Legal Sidebar, May 23, 2018
Coast Guard Polar Icebreaker Modernization: Background and Issues for Congress, updated May 23, 2018
Advanced Pilot Training (T-X) Program: Background and Issues for Congress, updated May 21, 2018
The International Monetary Fund, updated May 24, 2018
Prescription Drug Monitoring Programs, updated May 24, 2018
Vehicle Fuel Economy and Greenhouse Gas Standards: Frequently Asked Questions, May 24, 2018
Is There Liability for Cross-Border Shooting?, CRS Legal Sidebar, May 22, 2018
Maritime Territorial and Exclusive Economic Zone (EEZ) Disputes Involving China: Issues for Congress, updated May 24, 2018
Internet Freedom in China: U.S. Government Activity, Private Sector Initiatives, and Issues of Congressional Interest, May 18, 2018
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States’ biosecurity governance system is structurally incapable of detecting and responding to certain classes of threats. U.S. biosecurity tools have not kept pace with technological advancements or a changing threat landscape.